Abstract Search

ea0077oc4.3 | Adrenal and Cardiovascular | SFEBES2021

[¹¹C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism

Senanayake Russell , Gillett Daniel , Ali Zahabia , Bashari Waiel , MacFarlane James , Koulouri Olympia , van der Meulen Merel , Powlson Andrew , Challis Benjamin , Palma August , Hu Lihua , Aloj Luigi , Mendichovszky Iosif , Cuthbertson Dan , Shore Susannah , Levy Miles , Drake William , Brown Morris , Kosmoliaptsis Vasilis , Marker Alison , Cheow Heok , Gurnell Mark

Background: Primary aldosteronism (PA) is the leading, potentially reversible, cause of secondary hypertension. For most patients in whom surgery is being considered, adrenal vein sampling (AVS) is recommended to distinguish unilateral and bilateral causes. However, AVS remains technically challenging, and a significant proportion of patients are unable to progress to surgery because AVS is unavailable or unsuccessful. We have explored whether [11C]Metomidate PET/CT...

0 shares

Endocrine Abstracts

[¹¹C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism

BiosciAbstracts

Endocrine Abstracts

[11C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism

BiosciAbstracts

[¹¹C]Metomidate PET/CT can aid decision-making in patients with primary aldosteronism